A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancer

Observational studies have demonstrated a decreased incidence of cancers among users of HMG CoA reductase inhibitors (statins) and a reduced risk of recurrence among statin users diagnosed with early stage breast cancer. We initiated a prospective study to identify potential biomarkers of simvastati...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Higgins, Michaela J., Prowell, Tatiana M., Blackford, Amanda L., Byrne, Celia, Khouri, Nagi F., Slater, Shannon A., Jeter, Stacie C., Armstrong, Deborah K., Davidson, Nancy E., Emens, Leisha A., Fetting, John H., Powers, Pendleton P., Wolff, Antonio C., Green, Hannah, Thibert, Jacklyn N., Rae, James M., Folkerd, Elizabeth, Dowsett, Mitchell, Blumenthal, Roger S., Garber, Judy E., Stearns, Vered
Format: Artigo
Jezik:Inglês
Izdano: 2011
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3536477/
https://ncbi.nlm.nih.gov/pubmed/22076478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-011-1858-7
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items